These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23409762)

  • 1. Allosteric drugs and seven transmembrane receptors.
    Kenakin T
    Curr Top Med Chem; 2013; 13(1):5-13. PubMed ID: 23409762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric modulation as a unifying mechanism for receptor function and regulation.
    Changeux JP; Christopoulos A
    Diabetes Obes Metab; 2017 Sep; 19 Suppl 1():4-21. PubMed ID: 28880476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging paradigms in GPCR allostery: implications for drug discovery.
    Wootten D; Christopoulos A; Sexton PM
    Nat Rev Drug Discov; 2013 Aug; 12(8):630-44. PubMed ID: 23903222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic potential of allosteric ligands for free fatty acid sensitive GPCRs.
    Hudson BD; Ulven T; Milligan G
    Curr Top Med Chem; 2013; 13(1):14-25. PubMed ID: 23409763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synoptic pharmacology: Detecting and assessing the pharmacological significance of ligands for orphan receptors.
    Kenakin TP
    Pharmacol Res; 2016 Dec; 114():284-290. PubMed ID: 26804250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-protein coupled receptors as allosteric machines.
    Kenakin T
    Recept Channels; 2004; 10(2):51-60. PubMed ID: 15204035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G protein coupled receptors as allosteric proteins and the role of allosteric modulators.
    Kenakin T
    J Recept Signal Transduct Res; 2010 Oct; 30(5):313-21. PubMed ID: 20858023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Quantitative Characterization of Functional Allosteric Effects.
    Kenakin T
    Curr Protoc Pharmacol; 2017 Mar; 76():9.22.1-9.22.10. PubMed ID: 28306151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unravelling intrinsic efficacy and ligand bias at G protein coupled receptors: A practical guide to assessing functional data.
    Stott LA; Hall DA; Holliday ND
    Biochem Pharmacol; 2016 Feb; 101():1-12. PubMed ID: 26478533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives.
    Urwyler S
    Pharmacol Rev; 2011 Mar; 63(1):59-126. PubMed ID: 21228259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the Lipid Bilayer Orchestrate Access and Binding of Ligands to Transmembrane Orthosteric/Allosteric Sites of G Protein-Coupled Receptors?
    Szlenk CT; Gc JB; Natesan S
    Mol Pharmacol; 2019 Nov; 96(5):527-541. PubMed ID: 30967440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging opportunities for allosteric modulation of G-protein coupled receptors.
    Wang CI; Lewis RJ
    Biochem Pharmacol; 2013 Jan; 85(2):153-62. PubMed ID: 22975406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
    Burford NT; Watson J; Bertekap R; Alt A
    Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of tractable allosteric sites in G protein-coupled receptors.
    Wakefield AE; Mason JS; Vajda S; Keserű GM
    Sci Rep; 2019 Apr; 9(1):6180. PubMed ID: 30992500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of allosteric interactions at G protein-coupled receptors using radioligand binding assays.
    Leach K; Sexton PM; Christopoulos A
    Curr Protoc Pharmacol; 2011 Mar; Chapter 1():Unit 1.22. PubMed ID: 21935902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From allosteric drugs to allo-network drugs: state of the art and trends of design, synthesis and computational methods.
    Csermely P; Nussinov R; Szilágyi A
    Curr Top Med Chem; 2013; 13(1):2-4. PubMed ID: 23409761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Basis for Allosteric Modulation of Class B G Protein-Coupled Receptors.
    Wootten D; Miller LJ
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():89-107. PubMed ID: 31454292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric ligands for G protein-coupled receptors: a novel strategy with attractive therapeutic opportunities.
    De Amici M; Dallanoce C; Holzgrabe U; Tränkle C; Mohr K
    Med Res Rev; 2010 May; 30(3):463-549. PubMed ID: 19557759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular alliance-from orthosteric and allosteric ligands to dualsteric/bitopic agonists at G protein coupled receptors.
    Mohr K; Schmitz J; Schrage R; Tränkle C; Holzgrabe U
    Angew Chem Int Ed Engl; 2013 Jan; 52(2):508-16. PubMed ID: 23225228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying novel modulators of G protein-coupled receptors via interaction at allosteric sites.
    Presland J
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):567-76. PubMed ID: 16159018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.